Ingelheim, Germany (ots/PRNewswire) - - Not for Distribution or Publication in the United States New omnibus data from the largest global survey due to be published, conducted on the epidemiology of constipation, were presented today at the Digestive Disease Week congress in Los Angeles. The survey, sponsored by Boehringer Ingelheim, offers new insights into the incidence of constipation and shows that ...
Ingelheim, Germany (ots/PRNewswire) - - For Healthcare Professional and Consumer Journalists - Not for Distribution to USA Media - Survey Shows 25% of World's Population Suffer From Common and Distressing Ailment That can be Effectively Treated New data presented at the premier international gastroenterology congress Digestive Disease Week (DDW) 2006 ...
San Diego, California (ots/PRNewswire) - - For Accredited International Healthcare Journalists Only - Management of Exacerbations `Crucial' to Reduce COPD Mortality Survey results from the `Time to Live' report, presented today at the American Thoracic Society International Congress, show over two thirds of primary care physicians (66%) fear COPD will be ...
European Hematlogy Association
Rotterdam, Netherlands (ots/PRNewswire) - - RAI CONVENTION CENTRE, AMSTERDAM Presentation of results of groundbreaking hematological research in the fields of donor stem-cell transplantation and thrombosis The 11th Congress of the European Hematology Association (EHA) is being held from June 15 to 18 ...
Natick, Massachusetts and Paris (ots/PRNewswire) - - New Second-Generation Training Center in Brussels to Help Medical Professionals Advance Standard of Patient Care Boston Scientific Corporation (NYSE: BSX) today announced plans for the construction of a new state-of-the art medical training facility in ...
Somerville, New Jersey (ots/PRNewswire) - ETHICON Women's Health & Urology announced today that it received CE Mark approval in Europe to market the GYNECARE TVT SECUR(i) System for female stress urinary incontinence (SUI). This new mid-urethral sling device maintains many of the key elements that made GYNECARE TVT the gold standard in SUI surgery, and optimizes ...
Natick, Massachusetts (ots/PRNewswire) - - Results to Include Nine-Month Data on TAXUS(R) Liberte(TM) Stent Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company's major events and press announcements at the Paris Course on Revascularization (EuroPCR), which runs from May ...
Vienna, Austria (ots/PRNewswire) - Bristol-Myers Squibb Company (NYSE: BMY) today announced 96-week clinical trial results demonstrating that entecavir maintains more viral load suppression compared to lamivudine in nucleoside-naive, chronic hepatitis B e-antigen-negative (HBeAg-) patients. Data ...
Basel, Switzerland (ots/PRNewswire) - - Important Step Towards Broad Access of Herceptin for Women With Aggressive Form of Breast Cancer Roche today announced that the European Union's Committee for Human Medicinal Products (CHMP) has issued a positive recommendation for the use of Herceptin following surgery and standard chemotherapy as adjuvant treatment ...
Madrid (ots/PRNewswire) - - Revenue Amounted to 14.8 Million Euros - Marketing Expenditure Increased 52.1% to 5.1 Million Euros - The Group Invested 11.8 Million Euros in Research and Development, Up 32% Zeltia S.A. (ZEL SM; ZEL MC) today presented its financial results for the first quarter of 2006, which showed a significant increase in Research & Development (R&D) spend, to 11.8 million euros. ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. announced today that the Company has signed an option agreement with Cellgate Inc. of Redwood City, California. This agreement allows Isotechnika the option to obtain an exclusive license to develop and commercialize conjugates consisting of Cellgate's patented transporter technology for the topical delivery of ...
Madrid, Spain (ots/PRNewswire) - - Preliminary Tests Demonstrate That the NP031112 Molecule has a Very Innovative Therapeutic Potential - Phase I Will Consist of Two Stages: in the First One the Drug Will be Administrated in Scalating Single Doses, and in the Second One, in a Repeated Dose for Seven Days. Neuropharma, a subsidiary of the Zeltia Group ...
Natick, Massachusetts (ots/PRNewswire) - Boston Scientific Corporation (NYSE: BSX) today announced that it has completed its combination with Guidant Corporation (NYSE: GDT), creating a global leader in cardiovascular devices and one of the largest medical technology companies in the world. In a related transaction before the closing of the Boston Scientific-Guidant transaction, Guidant and Abbott closed ...
Bothell, Washington and Indianapolis, Indiana (ots/PRNewswire) - - Cialis Attains Leading ED Market Share Position in Eleven Countries - - 2006 First Quarter Net Income Soars to US$65.0 Million, Compared to Net Loss of US$41.7 Million in Prior Year Quarter - Lilly ICOS LLC (Lilly ICOS) (NYSE: LLY and Nasdaq: ICOS) is releasing its financial results for the 2006 first quarter, ended March 31. Worldwide ...
Washington D.c. (ots/PRNewswire) - PharmaMar today announces the presentation of five posters highlighting advances with three of its compounds at the 97th Annual Meeting of the American Association for Cancer Research (AACR), taking place in Washington from 1-5 April 2006. The posters include results from preclinical research on Aplidin(R), Zalypsis(R) and PM02734. PharmaMar's highlights from this year's AACR ...
Pompey, France (ots/PRNewswire) - Groupe Novasep is pleased to announce that Mr Thierry Favreau has been appointed President of its Novasep Process business. Thierry graduated from EDHEC and held several management and senor executive positions within Baxter, Becton Dickinson and Sanofi-Synthelabo. Prior to joining Groupe Novasep Thierry Favreau was CEO of Stedim Group.. "Growth will be driven by the ...
Research Triangle Park, North Carolina (ots/PRNewswire) - Quintiles Transnational Corp. today announced the appointment of Yoh Narimatsu as President and Chief Executive Officer of Quintiles Transnational Japan K.K. (Quintiles Japan) effective April 1. Narimatsu, who has more than 30 years of international business experience, will lead all operations of ...
Lund, Sweden (ots/PRNewswire) - - For Accredited International Medical Media Only AstraZeneca (LSE: AZN , NYSE: AZN) has today welcomed preliminary results from the TORCH (TOwards a Revolution in COPD Health) study1, suggesting combination therapies containing an inhaled corticosteroid (ICS) and long-acting beta 2 agonist (LABA) have the potential to show mortality benefits for COPD patients. The ...
Zurich, Suisse (ots/PRNewswire) - - Knowledge Gap of Concern to Both Physicians and Patient Groups Nine out of ten patients battling cancer in Europe have never heard of a major breakthrough in cancer treatment, known as anti-angiogenesis, according to a new survey released today. Yet, 70% of cancer ...
Ottawa, Canada (ots/PRNewswire) - The MDS Nordion Equinox, a state-of-the-art cancer therapy system, and Avanza, a patient positioning treatment table, have received CE Mark approval and are now commercially available in Europe. The Equinox is a unique external beam therapy system providing cancer care professionals with modern functionality to maximize productivity and increase flexibility ensuring patients ...
Research Triangle Park, North Carolina (ots/PRNewswire) - - Emerging U.S. company Aerovance Inc. studying COPD drug in U.K. Quintiles Transnational Corp. today announced that it has reached a significant milestone in data management -- the 200th clinical trial using Electronic Data Capture (EDC). Quintiles is using EDC in a trial being conducted in the United Kingdom for Aerovance, Inc., of Berkeley, ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. (TSX:ISA) announced today preliminary 48 week clinical data obtained from its Phase III psoriasis and extension trials for its lead immunosuppressive drug, ISA247. Patients completing the 24 week Canadian Phase III SPIRIT trial were given the opportunity to continue therapy for an additional 36 weeks or to ...
Indianapolis and San Diego (ots/PRNewswire) - - Trial to Study Use of Biomarker to Better Define Xigris Patients and Treatment Response Eli Lilly and Company (NYSE: LLY) and Biosite(R) Incorporated (Nasdaq: BSTE) today announced the two companies have signed an agreement to collaborate in connection with a clinical trial employing a tailored therapy ...
Toronto, Canada (ots/PRNewswire) - There are 18 million undernourished people and 7.5 million at risk of starvation and after six years of drought, crops across East Africa have failed again. National governments, local authorities and the United Nations need to respond in a timely matter as we have the means ...
Edmonton, Canada (ots/PRNewswire) - Isotechnika Inc. will announce preliminary 48 week clinical trial data for the Company's Canadian Phase III psoriasis trial for its lead immunosuppressive drug, ISA247, on Monday, March 20th at 8:00 a.m. EST/6:00 a.m. MST. Management will provide an overview of the preliminary 48 week Phase III data following the release ...
Vienna, Austria (ots/PRNewswire) - - New Data Demonstrate "Unique", Five Year Anti-Osteoporotic Efficacy Against Both Vertebral and Non-Vertebral Fractures New five year data presented at the 6th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO 6) meeting today show that the new osteoporosis treatment Protelos(R) ...
Tokyo, Japan (ots/PRNewswire) - Eisai Co., Ltd. (Headquarters: Tokyo, President and CEO: Haruo Naito) today announced preliminary results from the latest donepezil (Product name: ARICEPT(R)) study (Study 319) on the treatment of people with vascular dementia (VaD). Preliminary efficacy results show that those who received donepezil improved on measures of cognition, ...
Indianapolis (ots/PRNewswire) - - Enzastaurin Study Enrolling Patients with Glioblastoma One of the deadliest and rarest forms of cancer is the focus of a Phase III study initiated by Eli Lilly and Company today. Enzastaurin, an investigational, targeted, oral agent, will be evaluated at more than 100 sites worldwide for the treatment of relapsed glioblastoma multiforme (GBM), an aggressive and malignant form ...
Lyon, France (ots/PRNewswire) - - Influenza Vaccine Worldwide Leader sanofi pasteur Contributes to Italian Influenza Pandemic Preparedness Sanofi pasteur, the vaccines business of the sanofi-aventis Group(EURONEXT: SAN; NYSE: SNY), has supplied to the Italian Ministry of Health a stock of pre-pandemic vaccine against the H5N1 avian influenza virus ...
Ottawa, Canada (ots/PRNewswire) - MDS Nordion, the world's largest supplier of medical isotopes, is pleased to announce it has extended an exclusive agreement with Bruce Power to provide a reliable supply of cobalt until 2019. This partnership produces over 40% of the world's supply of cobalt, used primarily for the sterilisation of medical devices and consumer ...